Cargando…

Non-invasive bioluminescence imaging of HCoV-OC43 infection and therapy in the central nervous system of live mice

Human coronaviruses (HCoVs) are important pathogens that cause upper respiratory tract infections and have neuroinvasive abilities; however, little is known about the dynamic infection process of CoVs in vivo, and there are currently no specific antiviral drugs to prevent or treat HCoV infection. He...

Descripción completa

Detalles Bibliográficos
Autores principales:	Niu, Junwei, Shen, Liang, Huang, Baoying, Ye, Fei, Zhao, Li, Wang, Huijuan, Deng, Yao, Tan, Wenjie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier B.V. 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7114176/ https://www.ncbi.nlm.nih.gov/pubmed/31705922 http://dx.doi.org/10.1016/j.antiviral.2019.104646

Ejemplares similares

Adaptation of the endemic coronaviruses HCoV-OC43 and HCoV-229E to the human host
por: Forni, Diego, et al.
Publicado: (2021)

Improving human coronavirus OC43 (HCoV-OC43) research comparability in studies using HCoV-OC43 as a surrogate for SARS-CoV-2
por: Schirtzinger, Erin E., et al.
Publicado: (2022)

Titration of Human Coronaviruses, HCoV-229E and HCoV-OC43, by an Indirect Immunoperoxidase Assay
por: Lambert, Francine, et al.
Publicado: (2007)

Baculovirus expression of HCoV-OC43 nucleocapsid protein and development of a Western blot assay for detection of human antibodies against HCoV-OC43
por: Mourez, Thomas, et al.
Publicado: (2007)

Heparan Sulfate and Enoxaparin Interact at the Interface of the Spike Protein of HCoV-229E but Not with HCoV-OC43
por: Fuochi, Virginia, et al.
Publicado: (2023)

HCoV-Oc43–Induced Apoptosis of Murine Neuronal Cells
por: Jacomy, Hélène, et al.
Publicado: (2006)

HCoV-OC43–Induced Encephalitis is in Part Immune-Mediated
por: Butler, Noah, et al.
Publicado: (2006)

Montelukast Inhibits HCoV-OC43 Infection as a Viral Inactivator
por: Chen, Yongkang, et al.
Publicado: (2022)

Seasonality and immunity to laboratory-confirmed seasonal coronaviruses (HCoV-NL63, HCoV-OC43, and HCoV-229E): results from the Flu Watch cohort study
por: Aldridge, Robert W., et al.
Publicado: (2020)

Less severe course of COVID-19 is associated with elevated levels of antibodies against seasonal human coronaviruses OC43 and HKU1 (HCoV OC43, HCoV HKU1)
por: Dugas, Martin, et al.
Publicado: (2021)

Inhibition of coronavirus HCoV-OC43 by targeting the eIF4F complex
por: Feng, Yongmei, et al.
Publicado: (2022)

Inhibition by components of Glycyrrhiza uralensis of 3CLpro and HCoV-OC43 proliferation
por: Kim, Jang Hoon, et al.
Publicado: (2023)

A Mouse-Adapted Model of HCoV-OC43 and Its Usage to the Evaluation of Antiviral Drugs
por: Xie, Peifang, et al.
Publicado: (2022)

Effective inhibition of HCoV-OC43 and SARS-CoV-2 by phytochemicals in vitro and in vivo.
por: Ojha, Durbadal, et al.
Publicado: (2023)

Pan-Coronavirus CRISPR-CasRx Effector System Significantly Reduces Viable Titer in HCoV-OC43, HCoV-229E, and SARS-CoV-2
por: Mayes, Cathryn M., et al.
Publicado: (2023)

Erythromycin Estolate Is a Potent Inhibitor Against HCoV-OC43 by Directly Inactivating the Virus Particle
por: Wang, Xiaohuan, et al.
Publicado: (2022)

The 5′UTR of HCoV-OC43 adopts a topologically constrained structure to intrinsically repress translation
por: Mackeown, Matthew, et al.
Publicado: (2023)

Effect of andrographolide and deep eutectic solvent extracts of Andrographis paniculata on human coronavirus organ culture 43 (HCoV-OC43)
por: Komaikul, Jukrapun, et al.
Publicado: (2023)

Evaluating the Impact of gRNA SNPs in CasRx Activity for Reducing Viral RNA in HCoV-OC43
por: Mayes, Cathryn Michelle, et al.
Publicado: (2022)

Recent infection with HCoV-OC43 may be associated with protection against SARS-CoV-2 infection
por: Lavell, A.H. Ayesha, et al.
Publicado: (2022)

Antiviral Peptides Delivered by Chitosan-Based Nanoparticles to Neutralize SARS-CoV-2 and HCoV-OC43
por: Mali, Avinash, et al.
Publicado: (2023)

Murine encephalitis caused by HCoV-OC43, a human coronavirus with broad species specificity, is partly immune-mediated
por: Butler, Noah, et al.
Publicado: (2006)

Prevalence of Human Coronaviruses in Children and Phylogenetic Analysis of HCoV-OC43 during 2016–2022 in Riyadh, Saudi Arabia
por: Alamri, Khalid A., et al.
Publicado: (2022)

Comparative molecular epidemiology of two closely related coronaviruses, bovine coronavirus (BCoV) and human coronavirus OC43 (HCoV-OC43), reveals a different evolutionary pattern
por: KIN, Nathalie, et al.
Publicado: (2016)

Kurarinone Inhibits HCoV-OC43 Infection by Impairing the Virus-Induced Autophagic Flux in MRC-5 Human Lung Cells
por: Min, Jung Sun, et al.
Publicado: (2020)

Surveillance of endemic human coronaviruses (HCoV-NL63, OC43 and 229E) associated with childhood pneumonia in Kilifi, Kenya
por: Otieno, Grieven P., et al.
Publicado: (2020)

Targeting the m(6)A RNA modification pathway blocks SARS-CoV-2 and HCoV-OC43 replication
por: Burgess, Hannah M., et al.
Publicado: (2021)

Novel antiviral activity of PAD inhibitors against human beta-coronaviruses HCoV-OC43 and SARS-CoV-2
por: Pasquero, Selina, et al.
Publicado: (2022)

Nsp1 proteins of human coronaviruses HCoV-OC43 and SARS-CoV2 inhibit stress granule formation
por: Dolliver, Stacia M., et al.
Publicado: (2022)

Genomic Analysis of 15 Human Coronaviruses OC43 (HCoV-OC43s) Circulating in France from 2001 to 2013 Reveals a High Intra-Specific Diversity with New Recombinant Genotypes
por: Kin, Nathalie, et al.
Publicado: (2015)

Previous viral symptoms and individual mothers influenced the leveled duration of human milk antibodies cross-reactive to S1 and S2 subunits from SARS-CoV-2, HCoV-229E, and HCoV-OC43
por: Demers-Mathieu, Veronique, et al.
Publicado: (2021)

Epidemiology characteristics of human coronaviruses in patients with respiratory infection symptoms and phylogenetic analysis of HCoV-OC43 during 2010-2015 in Guangzhou
por: Zhang, Su-fen, et al.
Publicado: (2018)

Sulforaphane exhibits antiviral activity against pandemic SARS-CoV-2 and seasonal HCoV-OC43 coronaviruses in vitro and in mice
por: Ordonez, Alvaro A., et al.
Publicado: (2022)

Betacoronaviruses SARS-CoV-2 and HCoV-OC43 infections in IGROV-1 cell line require aryl hydrocarbon receptor
por: Yousefi, Meisam, et al.
Publicado: (2023)

Coronavirus humains (HCoV)
por: Vabret, A., et al.
Publicado: (2009)

Human Milk Antibodies against S1 and S2 Subunits from SARS-CoV-2, HCoV-OC43, and HCoV-229E in Mothers with a Confirmed COVID-19 PCR, Viral SYMPTOMS, and Unexposed Mothers
por: Demers-Mathieu, Veronique, et al.
Publicado: (2021)

Use of whole-genome sequencing in the molecular investigation of care-associated HCoV-OC43 infections in a hematopoietic stem cell transplant unit
por: Beury, Delphine, et al.
Publicado: (2020)

Pre-existing anti-HCoV-OC43 immunity influences the durability and cross-reactivity of humoral response to SARS-CoV-2 vaccination
por: Hu, Caiqin, et al.
Publicado: (2022)

Genetic tracing of HCoV-19 for the re-emerging outbreak of COVID-19 in Beijing, China
por: Yang, Jing, et al.
Publicado: (2020)

Combined in silico and in vitro approaches identified the antipsychotic drug lurasidone and the antiviral drug elbasvir as SARS-CoV2 and HCoV-OC43 inhibitors
por: Milani, Mario, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_49cfadv1uujljrggfgnc4rnc33